HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M300023-JLR200v1 44/7/1341    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prinsen, B. H. C. M. T. Articles by de Sain-van der Velden, M. G. M. Search for Related Content PubMed PubMed Citation Articles by Prinsen, B. H. C. M. T. Articles by de Sain-van der Velden, M. G. M. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 44, 1341-1348, July 2003
Copyright © 2003 by American Society for Biochemistry and Molecular Biology

Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans

Berthil H. C. M. T. Prinsen^*,, Johannes A. Romijn, Peter H. Bisschop^**, Martina M. J. de Barse, P. Hugh R. Barrett, Mariëtte Ackermans^**, Ruud Berger, Ton J. Rabelink and Monique G. M. de Sain-van der Velden^1,

^* Department of Vascular Medicine and Metabolism, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Metabolic Diseases, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Endocrinology, Leiden, University Medical Center, The Netherlands
^** Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, The Netherlands
Department of Medicine, University of Western Australia and the Western Australia Institute for Medical Research, Perth, Australia

¹ To whom correspondence should be addressed. e-mail: m.g.desain{at}lab.azu.nl

Subjects with high plasma cholesterol levels exhibit a high production of VLDL apolipoprotein B-100 (apoB-100), suggesting that cholesterol is a mediator for VLDL production. The objective of the study was to examine whether endogenous cholesterol synthesis, reflected by the lathosterol-cholesterol ratio (L-C ratio), affects the secretory rates of different VLDL subfractions. Ten healthy subjects were studied after overnight fasting. During a 10 h primed, constant infusion of ¹³C-valine (15 µmol/kg/h), enrichment was determined in apoB-100 from ultracentrifugally isolated VLDL-1 and VLDL-2 by gas chromatography mass spectrometry. The synthesis rates of VLDL-1 apoB-100 and VLDL-2 apoB-100, catabolism, and transfer were estimated by compartmental analysis. Mean VLDL-1 apoB-100 pool size was 90 ± 15 mg, and mean VLDL-2 apoB-100 pool size was 111 ± 14 mg. Absolute synthesis rate of VLDL-1 apoB-100 was 649 ± 127 mg/day and 353 ± 59 mg/day for VLDL-2 apoB-100. There was a strong association between the absolute synthesis rate of VLDL-2 apoB-100 and L-C ratio (r ² = 0.61, P < 0.01). In contrast, no correlation was observed between L-C ratio and absolute synthesis rate of VLDL-1 apoB-100 (r ² = 0.302, P = 0.09). In conclusion, these data provide additional support for an independent regulation of VLDL-1 apoB-100 and VLDL-2 apoB-100 production.

Endogenous cholesterol synthesis is correlated only with the VLDL-2 apoB-100 production.

Supplementary key words apolipoprotein B-100 • lathosterol • very low density lipoprotein

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Adiels, S.-O. Olofsson, M.-R. Taskinen, and J. Boren Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1225 - 1236. [Abstract] [Full Text] [PDF]

				F. Basso, L. A. Freeman, C. Ko, C. Joyce, M. J. Amar, R. D. Shamburek, T. Tansey, F. Thomas, J. Wu, B. Paigen, et al. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited J. Lipid Res., January 1, 2007; 48(1): 114 - 126. [Abstract] [Full Text] [PDF]

				M. C. Nierman, B. H.C.M.T. Prinsen, J. Rip, R. J. Veldman, J. A. Kuivenhoven, J. J.P. Kastelein, M. G.M. de Sain-van der Velden, and E. S.G. Stroes Enhanced Conversion of Triglyceride-Rich Lipoproteins and Increased Low-Density Lipoprotein Removal in LPLS447X Carriers Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2410 - 2415. [Abstract] [Full Text] [PDF]

				G D Kolovou, K K Anagnostopoulou, and D V Cokkinos Pathophysiology of dyslipidaemia in the metabolic syndrome Postgrad. Med. J., June 1, 2005; 81(956): 358 - 366. [Abstract] [Full Text] [PDF]

				J. P.H. van Wijk, E. J.P. de Koning, M. Castro Cabezas, and T. J. Rabelink Rosiglitazone Improves Postprandial Triglyceride and Free Fatty Acid Metabolism in Type 2 Diabetes Diabetes Care, April 1, 2005; 28(4): 844 - 849. [Abstract] [Full Text] [PDF]

				L. Berglund and D. Hyson Cholesterol Absorption and the Metabolic Syndrome: A New Look at an Old Area Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1314 - 1316. [Full Text] [PDF]